Literature DB >> 15215135

In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Carolina Serena1, Francisco Javier Pastor, Montserrat Ortoneda, Javier Capilla, Nicole Nolard, Josep Guarro.   

Abstract

The in vitro activities of eight antifungal drugs against 50 isolates of basidiomycetous yeasts were determined by a microdilution method. In general fluconazole and micafungin were inactive. Terbinafine was active only against Sporobolomyces salmonicolor. The activities of the other antifungals were variable and depended on the species tested. The new triazoles showed the lowest MICs, but amphotericin B and itraconazole were the only drugs active against Cryptococcus albidus.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215135      PMCID： PMC434224          DOI： 10.1128/AAC.48.7.2724-2726.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Uncommon opportunistic fungi: new nosocomial threats.

Authors:  A H Groll; T J Walsh
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

2.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

3.  Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia.

Authors:  J R Ebright; M R Fairfax; J A Vazquez
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

4.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 5.  Trichosporon beigelii infection: experience in a regional burn center.

Authors:  M J Cawley; G R Braxton; L R Haith; K J Reilly; R E Guilday; M L Patton
Journal:  Burns       Date:  2000-08       Impact factor: 2.744

6.  An evaluation of the in vitro activity of terbinafine.

Authors:  C J Jessup; N S Ryder; M A Ghannoum
Journal:  Med Mycol       Date:  2000-04       Impact factor: 4.076

7.  First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.

Authors:  T Kordossis; A Avlami; A Velegraki; I Stefanou; G Georgakopoulos; C Papalambrou; N J Legakis
Journal:  Med Mycol       Date:  1998-10       Impact factor: 4.076

8.  Trichosporon species infection in bone marrow transplanted patients.

Authors:  M L Moretti-Branchini; K Fukushima; A Z Schreiber; K Nishimura; P M Papaiordanou; P Trabasso; R Tanaka; M Miyaji
Journal:  Diagn Microbiol Infect Dis       Date:  2001-03       Impact factor: 2.803

9.  Persistent fungemia--risk factors and outcome in 40 episodes.

Authors:  G Kovacicova; M Lovaszova; J Hanzen; A Roidova; F Mateicka; M Lesay; V Krcméry
Journal:  J Chemother       Date:  2001-08       Impact factor: 1.714

10.  In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.

Authors:  S Tawara; F Ikeda; K Maki; Y Morishita; K Otomo; N Teratani; T Goto; M Tomishima; H Ohki; A Yamada; K Kawabata; H Takasugi; K Sakane; H Tanaka; F Matsumoto; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191
View more
  6 in total

1.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Cryptococcus laurentii biofilms: structure, development and antifungal drug resistance.

Authors:  K Ajesh; K Sreejith
Journal:  Mycopathologia       Date:  2012-09-01       Impact factor: 2.574

3.  Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.

Authors:  Carolina Serena; F Javier Pastor; Félix Gilgado; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.

Authors:  Carolina Serena; Belkys Fernández-Torres; F Javier Pastor; Luciana Trilles; Márcia Dos Santos Lazéra; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 5.  Case Report of Cryptococcus Albidus Peritonitis in a Peritoneal Dialysis Patient and a Review of the Literature.

Authors:  Loheetha Ragupathi; Maria Reyna
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

6.  Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.